Genetic variability in coding regions of the surface antigen and reverse transcriptase domain of hepatitis B virus polymerase, Colombia, 2002-2014
Abstract
Introduction: Despite the availability of an effective vaccine and treatment to reduce the viral load and progressive hepatocellular injury, approximately 240 million people worldwide are chronically infected with the hepatitis B virus (HBV). In Colombia, the circulation of different viral genotypes has been confirmed. Mutations in the genome have been associated to antiviral therapy resistance, viral escape to neutralizing antibodies, occult infection and progression to hepatocellular carcinoma.
Objective: To identify the genotypes and the presence of mutations in the coding region of the surface (S) antigen and the reverse transcriptase (RT) domain of the polymerase of HBV obtained from serum samples for hepatitis B diagnosis received by the Instituto Nacional de Salud during the period 2002-2014.
Materials and methods: A total of 495 serum samples with previous HBsAg reactive result were used for molecular detection. A fragment of 1,591 nucleotides was sequenced, and the corresponding phylogenetic analysis was performed.
Results: We detected the viral genome of HBV in 66 samples and 28 were successfully sequenced. The phylogenetic analysis allowed the identification of subgenotypes F3 and A2. The L180M and M204V resistance mutations were simultaneously identified in one sample, while the I169L resistance mutation was identified in another one. A single escape mutation, P120Q, was identified in one more. Two samples showed a deletion of 105 nucleotides in the preS1-preS2 region.
Conclusions: The circulation of genotypes/subgenotypes F3 and A2 of HBV in Colombia was corroborated, as well as the presence of some resistance and escape mutations. The present study constitutes a contribution to the molecular epidemiology of HBV in Colombia.
Downloads
References
Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008; 359:1486-500. https://doi.org/10.1056/NEJMra0801644
Paganelli M, Stephenne X, Sokal EM. Chronic hepatitis B in children and adolescents. J Hepatol. 2012;57:885-96. https://doi.org/10.1016/j.jhep.2012.03.036
World Health Organization. Hepatitis B. Fact sheet. 2016. Fecha de consulta: 1° de julio de 2017. Disponible en: http://www.who.int/mediacentre/factsheets/fs204/en/
Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-55. https://doi.org/10.1016/S0140-6736(15)61412-X
Instituto Nacional de Salud. Sivigila. Boletín epidemiológico semanal. Semana epidemiológica No. 52 de 2016. Bogotá: Instituto Nacional de Salud; 2016. Fecha de consulta: 22 de febrero de 2017. Disponible en: http://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2016%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2052%20-.pdf
Alvarado-Mora MV, Fernández MF, Gomes-Gouvêa MS, de Azevedo-Neto RS, Carrilho FJ, Pinho JR. Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation? PLoS One. 2011;6:e18888. https://doi.org/10.1371/journal.pone.0018888
Ríos-Patiño D, di Filippo VD, Insuasty EM, Rendón JC, Ríos WA, Medina LC, et al. Hepatitis B infections in individuals with exposure factors in Quibdó and Apartadó, Colombia. Rev Colomb Gastroenterol. 2015;30:11-8.
Di Filippo-Villa D, Cortés-Mancera F, Payares E, Montes N, de la Hoz F, Arbeláez MP, et al. Hepatitis D virus and hepatitis B virus infection in Amerindian communities of the Amazonas state, Colombia. Virol J. 2015;12:172. https://doi.org/10.1186/s12985-015-0402-5
Beltrán M, Navas MC, Arbeláez MP, Donado J, Jaramillo S, De la Hoz F, et al. Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia, Sur América. Biomédica. 2009;29:232-43. https://doi.org/10.7705/biomedica.v29i2.25
Seeger C, Zoulim F, Mason WS. Hepadnaviruses. In: Knipe D, Howley P, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 2185-221.
Norder H, Courouce AM, Coursaget P, Echevarría JM, Lee SD, Mushahwar IK, et al. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47:289-309. https://doi.org/10.1159/000080872
Shi W, Zhang Z, Ling C, Zheng W, Zhu C, Carr MJ, et al. Hepatitis B virus subgenotyping: History, effects of recombination, misclassifications, and corrections. Infect Genet Evol. 2013;16:355-61. https://doi.org/10.1016/j.meegid.2013.03.021
Bautista-Amorocho H, Castellanos-Domínguez YZ, Rodríguez-Villamizar LA, Velandia-Cruz SA, Becerra-Peña JA, Farfán-García AE. Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: High prevalence of occult hepatitis B and F3 subgenotype dominance. PLoS One. 2014;9:e114272. https://doi.org/10.1371/journal.pone.0114272
Cortés-Mancera F, Loureiro CL, Hoyos S, Restrepo JC, Correa G, Jaramillo S, et al. Etiology and viral genotype in patients with end-stage liver diseases admitted to a hepatology unit in Colombia. Hepat Res Treat. 2011;2011:363205. https://doi.org/10.1155/2011/363205
Alvarado-Mora MV, Romano CM, Gomes-Gouvêa MS, Gutiérrez MF, Carrilho FJ, Pinho JR. Molecular epidemiology and genetic diversity of hepatitis B virus genotype E in an isolated Afro-Colombian community. J Gen Virol. 2010;91:501-8. https://doi.org/10.1099/vir.0.015958-0
Alvarado-Mora MV, Romano CM, Gomes-Gouvêa MS, Gutiérrez MF, Botelho L, Carrilho FJ, et al. Molecular characterization of the hepatitis B virus genotypes in Colombia: A Bayesian inference on the genotype F. Infect Genet Evol. 2011;11:103-8. https://doi.org/10.1016/j.meegid.2010.10.003
Devesa M, Loureiro CL, Rivas Y, Monsalve F, Cardona N, Duarte MC, et al. Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol. 2008;80:20-6. https://doi.org/10.1002/jmv.21024
Alvarado-Mora MV, Romano CM, Gomes-Gouvêa MS, Gutiérrez MF, Carrilho FJ, Pinho JR. Phylogenetic analysis of complete genome sequences of hepatitis B virus from an Afro-Colombian community: Presence of HBV F3/A1 recombinant strain. Virol J. 2012;9:244. https://doi.org/10.1186/1743-422X-9-244
Rendón JC, Cortés-Mancera F, Duque-Jaramillo A, Ospina MC, Navas MC. Analysis of hepatitis B virus genotypes by restriction fragment length polymorphism. Biomédica. 2016;36:79-88. https://doi.org/10.7705/biomedica.v36i0.2976
Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57:141-50. https://doi.org/10.1159/000360947
Tong S, Revill P. Overview of hepatitis B viral replication and genetic variability. J Hepatol. 2016;64(Suppl.):S4-16. https://doi.org/10.1016/j.jhep.2016.01.027
Fan YF, Lu CC, Chen WC, Yao WJ, Wang HC, Chang TT, et al. Prevalence and significance of hepatitis B virus (HBV) pre-S mutants in serum and liver at different replicative stages of chronic HBV infection. Hepatology. 2001;33:277-86. https://doi.org/10.1053/jhep.2001.21163
Jaramillo CM, Navas MC. Variantes de escape del virus de la hepatitis B. Rev Chil Infectol. 2015;32:190-7. https://doi.org/10.4067/S0716-10182015000300008
Biswas S, Candotti D, Allain JP. Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol. 2013;87:7882-92. https://doi.org/10.1128/JVI.00710-13
Coleman PF. Surveillance for hepatitis B surface antigen mutants. J Med Virol. 2006;78(Suppl.1):S56-8. https://doi.org/10.1002/jmv.20609/abstract
Stuyver L, De Gendt S, van Geyt C, Zoulim F, Fried M, Schinazi RF, et al. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol. 2000;81:67-74. https://doi.org/10.1099/0022-1317-81-1-67
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30:2725-9. https://doi.org/10.1093/molbev/mst197
Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: More models, new heuristics and parallel computing. Nat Methods. 2012:9;772. https://doi.org/10.1038/nmeth.2109
Rhee SY, Margeridon-Thermet S, Nguyen MH, Liu TF, Kagan RM, Beggel B, et al. Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discovery. Antiviral Res. 2010;88:269-75. https://doi.org/10.1016/j.antiviral.2010.09.012
Beggel B, Neumann-Fraune M, Doring M, Lawyer G, Kaiser R, Verheyen J, et al. Genotyping hepatitis B virus dual infections using population-based sequence data. J Gen Virol. 2012;93:1899-907. https://doi.org/10.1099/vir.0.043042-0
Mukaide M, Tanaka Y, Shin IT, Yuen MF, Kurbanov F, Yokosuka O, et al. Mechanism of entecavir resistance of hepatitis B virus with viral breakthrough as determined by long-term clinical assessment and molecular docking simulation. Antimicrob Agents Chemother. 2010;54:882-9. https://doi.org/10.1128/AAC.01061-09
He X, Wang F, Huang B, Chen P, Zhong L. Detection and analysis of resistance mutations of hepatitis B virus. Int J Clin Exp Med. 2015;8:9630-9.
Rendón JC, Cortés-Mancera F, Restrepo-Gutiérrez JC, Hoyos S, Navas MC. Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia. PLoS One. 2017;12:e0180447. https://doi.org/10.1371/journal.pone.0180447
Kim DY, Chang HY, Lim SM, Kim SU, Park JY, Kim JK, et al. Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. Gut Liver. 2013;7:329-34. https://doi.org/10.5009/gnl.2013.7.3.329
Beltrán M, Berrío-Pérez M, Bermúdez MI, Rey-Benito G, Camacho B, Forero P, et al. Detección de hepatitis B oculta en donantes de bancos sangre,Colombia 2008-2009. Biomédica. 2011;31:580-9. https://doi.org/10.7705/biomedica.v31i4.446
de la Hoz F. Comportamiento de la notificación por Sivigila para hepatitis B, 1997-2001. Inf Quinc Epidemiol Nac. 2001;6:253-68.
Idrovo-Cubides V, Suárez Q CY, Álvarez-Quintero P. Epidemiología e historia natural de la hepatitis B. Rev Colomb Gastroenterol. 2009;24:4s-12s.
Beltrán O, Varón A, Restrepo JC. Hepatitis B postrasplante. Rev Colomb Gastroenterol. 2009;24(Supl.1):33-8S.
Kramvis A, Kew MC. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat. 2005;12:456-64. https://doi.org/10.1111/j.1365-2893.2005.00624.x/abstract
Tolosa N, Cuéllar C, Quijada H, Pacheco OE, Escalante M, Usme-Ciro JA, et al. Estudio de conglomerado de casos de hepatitis B en el Establecimiento Penitenciario de Mediana y Alta Seguridad (EPMAS) “Doña Juana”, municipio La Dorada (Caldas), año 2014. Inf Quinc Epidemiol Nac. 2016;21:216-37.
Mohanty K. The first case of criminalization of transmission of hepatitis B in the UK: Defendant sentenced to two years’ imprisonment on the grounds of hepatitis B deoxyribonucleic acid sequencing. Int J STD AIDS. 2009;20:587-9. https://doi.org/10.1258/ijsa.2008.008483
Campos RH, Mbayed VA, Pineiro YL. Molecular epidemiology of hepatitis B virus in Latin America. J Clin Virol. 2005;34(Suppl.2):S8-s13. https://doi.org/10.1016/S1386-6532(05)80028-9
Paraskevis D, Magiorkinis G, Magiorkinis E, Ho SY, Belshaw R, Allain JP, et al. Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology. 2013;57:908-16. https://doi.org/10.1002/hep.26079
Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, Homan CE, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: Preponderance of genotype F. J Infect Dis. 2007;195:5-11. https://doi.org/10.1086/509894
Sánchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients. Gastroenterology. 2002;123:1848-56. https://doi.org/10.1053/gast.2002.37041
Norder H, Courouce AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology. 1994;198:489-503. https://doi.org/10.1006/viro.1994.1060
Matsuura K, Tanaka Y, Hige S, Yamada G, Murawaki Y, Komatsu M, et al. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol. 2009;47:1476-83. https://doi.org/10.1128/JCM.02081-08
Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, Yamamoto M, et al. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci USA. 1989;86:7059-62.
Girones R, Miller RH. Mutation rate of the hepadnavirus genome. Virology. 1989;170:595-7.
Waters JA, Kennedy M, Voet P, Hauser P, Petre J, Carman W, et al. Loss of the common “A” determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest. 1992;90:2543-7. https://doi.org/10.1172/JCI116148
Carman WF, Korula J, Wallace L, MacPhee R, Mimms L, Decker R. Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet. 1995;345:1406-7.
Avellón A, Echevarría JM. Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol. 2006;78:24-36. https://doi.org/10.1002/jmv.20516/abstract
Kfoury-Baz EM, Zheng J, Mazuruk K, van Le A, Peterson DL. Characterization of a novel hepatitis B virus mutant: Demonstration of mutation-induced hepatitis B virus surface antigen group specific “a” determinant conformation change and its application in diagnostic assays. Transfus Med. 2001;11:355-62. https://doi.org/10.1046/j.1365-3148.2001.00323.x
Lee KM, Kim YS, Ko YY, Yoo BM, Lee KJ, Kim JH, et al. Emergence of vaccine-induced escape mutant of hepatitis B virus with multiple surface gene mutations in a Korean child. J Korean Med Sci. 2001;16:359-62. https://doi.org/10.3346/jkms.2001.16.3.359
Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 2006;130:1153-68. https://doi.org/10.1053/j.gastro.2006.01.011
Pollicino T, Amaddeo G, Restuccia A, Raffa G, Alibrandi A, Cutroneo G, et al. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology. 2012;56:434-43. https://doi.org/10.1002/hep.25592
Zhang D, Dong P, Zhang K, Deng L, Bach C, Chen W, et al. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment. BMC Microbiol. 2012;12:307. https://doi.org/10.1186/1471-2180-12-307
Santantonio T, Jung MC, Schneider R, Fernholz D, Milella M, Monno L, et al. Hepatitis B virus genomes that cannot synthesize pre-S2 proteins occur frequently and as dominant virus populations in chronic carriers in Italy. Virology. 1992;188:948-52. https://doi.org/10.1016/0042-6822(92)90559-8
Some similar items:
- Julio-C Rendón, Fabián Cortés-Mancera, Alejandra Duque-Jaramillo, Marta C. Ospina, María Cristina Navas, Analysis of hepatitis B virus genotypes by restriction fragment length polymorphism , Biomedica: Vol. 36 (2016): Suplemento 2, Enfermedades virales
- María Claudia Atencia, María de Jesús Pérez, María Cristina Jaramillo, Sandy Milena Caldera, Suljey Cochero, Eduar Elías Bejarano, First report of the F1534C mutation associated with cross-resistance to DDT and pyrethroids in Aedes aegypti from Colombia , Biomedica: Vol. 36 No. 3 (2016)
- Mauricio Beltrán, María Cristina Navas, María Patricia Arbeláez, Jorge Donado, Sergio Jaramillo, Fernando De la Hoz, Cecilia Estrada, Lucía del Pilar Cortés, Amalia de Maldonado, Gloria Rey, Seroprevalence of hepatitis B virus and human immunodeficiency virus infection in a population of multiply-transfused patients in Colombia , Biomedica: Vol. 29 No. 2 (2009)
- Liliana Franco-Hincapié, Constanza Elena Duque, María Victoria Parra, Natalia Gallego, Alberto Villegas, Andrés Ruiz-Linares, Gabriel Bedoya, Association between polymorphism in uncoupling proteins and type 2 diabetes in a northwestern Colombian population , Biomedica: Vol. 29 No. 1 (2009)
- Amanda Maestre, Jaime Carmona-Fonseca, Amanda Maestre, Alta frecuencia de mutaciones puntuales en pfcrt de Plasmodium falciparum y emergencia de nuevos haplotipos mutantes en Colombia , Biomedica: Vol. 28 No. 4 (2008)
- Alberto Gómez, Sandra J. Ávila, Ignacio Briceño, Correlation analysis of surnames and Y-chromosome genetic heritage in 3 provinces of southwestern Colombia , Biomedica: Vol. 28 No. 3 (2008)
- John Alexander Galindo, Fabio Aníbal Cristiano, Angélica Knudson, Rubén Santiago Nicholls, Ángela Patricia Guerra, Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum from three endemic malaria regions in Colombia , Biomedica: Vol. 30 No. 1 (2010)
- Libia M. Rodríguez, Mabel C. Giraldo, Natalia García, Laura Velásquez, Sara C. París, Cristiam M. Álvarez, Luis F. García, Human leucocyte antigen gene (HLA-A, HLA-B, HLA-DRB1) frequencies in deceased organ donors , Biomedica: Vol. 27 No. 4 (2007)
- Laura C. Álvarez-Acevedo, María C. Zuleta-González, Óscar M. Gómez-Guzmán, Álvaro L. Rúa-Giraldo, MSc PhD, M.D. PhD, Martha E. Urán-Jiménez, Myrtha Arango-Arteaga, MSc PhD, Manoel Marques Evangelista de Oliveira, María del P. Jiménez-Alzate, Phenotypic and genotypic characterization of Colombian clinical isolates of Sporothrix spp. , Biomedica: Vol. 43 No. Sp. 1 (2023): Agosto, Micología médica
- Lucero Rengifo, Duverney Gaviria, Herman Serrano, APOE gene polymorphisms associated with Down syndrome in Colombian populations , Biomedica: Vol. 32 No. 2 (2012)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
